We used the β-catenin agonist LiCl (40 mM), which could completely rescue the phenotype of ARHGEF11 silence, including proliferation and migration of hepatoma cells (Supplementary Figure 2A, 2B). The gene discussed is ARHGEF11; the disease is hepatocellular carcinoma.